PRA Health Sciences Archives | Page 3 of 4

Home / Posts tagged PRA Health Sciences (Page 3)

PRA Health Sciences Announces Strategic Alliance Between Symphony Health and Close-Up International

RALEIGH, N.C., Aug. 19 (Korea Bizwire) — PRA Health Sciences (NASDAQ: PRAH) announced today that Symphony Health, the company’s data solutions division, has expanded its global data services by entering into a strategic partnership with Close-Up International, a leading Latin American-based provider of medical prescription and sales audits. “The agreement with Close-Up represents a significant milestone [...]

PRA Named International Clinical Research Company of the Year

RALEIGH, N.C., May 24 (Korea Bizwire) — PRA Health Sciences, Inc. (NASDAQ:PRAH) is pleased to announce it was recognized by PharmaTimes as the International Clinical Research Company of the Year. This is the fifth year in a row that PRA has received this award. “This award celebrates excellence in the clinical research industry and we [...]

PRA Health Sciences Named Best CRO in Asia

RALEIGH, N.C., Mar. 6 (Korea Bizwire) — PRA Health Sciences, Inc. (NASDAQ:PRAH) is honored to once again be named Best CRO in Asia. PRA received this recognition at the Phar-East Pharma and Biotech Festival (formally known as BioPharma Asia). This is the fourth time PRA has received this award since 2013. The award recognizes the [...]

PRA Health Sciences Named International Clinical Research Company of the Year

RALEIGH, N.C., May 22 (Korea Bizwire) — PRA Health Sciences, Inc., (PRA) (NASDAQ:PRAH) is pleased to announce that for the fourth consecutive year it was recognized as the International Clinical Research Company of the Year. PRA received the award at a PharmaTimes ceremony in London. This award follows PRA’s recent recognition as Clinical Research Company [...]

PRA Health Sciences Announces the Center for Pediatric Clinical Development

RALEIGH, N.C, May 4 (Korea Bizwire) — It is a little known fact that 70% of medicines given to children have been studied only in adults. As a result, most drugs used to treat diseases in children are used off-label. While there are pediatric clinical trial regulations in place, testing drugs in children continues to [...]

PRA Health Sciences Named International Clinical Research Company of the Year

RALEIGH, N.C., May 17 (Korea Bizwire) — PRA Health Sciences, Inc., (PRA) (NASDAQ:PRAH) is pleased to announce that for the third consecutive year it was recognized as the Clinical Research Company of the Year. PRA received the award at the PharmaTimes International Clinical Researcher of the Year ceremony in London. This award follows PRA’s recent [...]

PRA Health Sciences Expands Operations in Singapore

RALEIGH, N.C., Nov. 16 (Korea Bizwire) — PRA Health Sciences (PRA) (NASDAQ:PRAH) is pleased to announce that it is relocating to a new office in Singapore to support its expanded operations in the region. The move will allow PRA to consolidate its workforce and be strategically located near many of its clients in the area. [...]

PRA Health Sciences Opens New Bioanalytical Laboratory in the Netherlands

RALEIGH, N.C., Oct. 26 (Korea Bizwire) — PRA Health Sciences (PRA) (NASDAQ:PRAH) is pleased to announce the opening of its brand new, state-of-the-art Bioanalytical Laboratory in Assen, the Netherlands. The 33,000 square foot facility provides 25 percent more space than PRA’s previous lab, includes investments in the newest small and large molecule equipment, and allows [...]

PRA Health Sciences Launches New Initiative to Bolster Workforce

RALEIGH, N.C., Jul. 20 (Korea Bizwire) — PRA Health Sciences (PRA) (NASDAQ:PRAH) is looking to hire new talent. To help attract potential employees from around the world, PRA, a leading global contract research organization (CRO), is launching a new Candidate Experience initiative. Just as PRA is finding innovative ways to improve the clinical development process, [...]

PRA Continues the Transformation of Clinical Trials with Predictivv(TM)

RALEIGH, N.C., Jun. 15 (Korea Bizwire) — PRA Health Sciences (Nasdaq:PRAH), a leading global contract research organization, today announced its new Predictivv(TM) platform, the beginning of an entirely new approach on the role technology will play in the future of clinical development. The Predictivv(TM) platform will be a fully integrated solution for designing, planning and [...]